Please assess the completion status of the following clinical trial:

Trial Title: The AOT (Acridine Orange and Taurolidine) Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* informed consent~* patient on home TPN with central line (Hickman or Porth-a-cath)~* suspected central line infection (acridine orange test)~* proven central line infection (randomisation tauroline vs heparin)~Exclusion Criteria:~* no informed consent~* patient on home TPN with arteriovenous fistula (shunt)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).